> Details

Campos-Varela, Isabel; Villagrasa, Ares; Simon-Talero, Macarena; Riveiro-Barciela, Mar; Ventura-Cots, Meritxell; Aguilera-Castro, Lara; Alvarez-Lopez, Patricia; Nordahl, Emilie A; Anton, Adrian; Bañares, Juan; Barber, Claudia; Barreira-Diaz, Ana; Biagetti, Betina; Camps-Relats, Laura; Ciudin, Andrea; Cocera, Raul; Dopazo, Cristina; Fernandez, Andrea; Jimenez, Cesar; Jimenez, Maria M; Jofra, Mariona; Gil, Clara; Gomez-Gavara, Concepción; Guanozzi, Danila; [...]

The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19
  • Contributor: Campos-Varela, Isabel; Villagrasa, Ares; Simon-Talero, Macarena; Riveiro-Barciela, Mar; Ventura-Cots, Meritxell; Aguilera-Castro, Lara; Alvarez-Lopez, Patricia; Nordahl, Emilie A; Anton, Adrian; Bañares, Juan; Barber, Claudia; Barreira-Diaz, Ana; Biagetti, Betina; Camps-Relats, Laura; Ciudin, Andrea; Cocera, Raul; Dopazo, Cristina; Fernandez, Andrea; Jimenez, Cesar; Jimenez, Maria M; Jofra, Mariona; Gil, Clara; Gomez-Gavara, Concepción; Guanozzi, Danila; [...]
  • imprint: SAGE Publications, 2021
  • Published in: Therapeutic Advances in Gastroenterology
  • Language: English
  • DOI: 10.1177/17562848211016567
  • ISSN: 1756-2848
  • Keywords: Gastroenterology
  • Origination:
  • Footnote:
  • Description: <jats:p> Liver injury has been widely described in patients with Coronavirus disease 2019 (COVID-19). We aimed to study the effect of liver biochemistry alterations, previous liver disease, and the value of liver elastography on hard clinical outcomes in COVID-19 patients. We conducted a single-center prospective observational study in 370 consecutive patients admitted for polymerase chain reaction (PCR)-confirmed COVID-19 pneumonia. Clinical and laboratory data were collected at baseline and liver parameters and clinical events recorded during follow-up. Transient elastography [with Controlled Attenuation Parameter (CAP) measurements] was performed at admission in 98 patients. All patients were followed up until day 28 or death. The two main outcomes of the study were 28-day mortality and the occurrence of the composite endpoint intensive care unit (ICU) admission and/or death. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were elevated at admission in 130 patients (35%) and 167 (45%) patients, respectively. Overall, 14.6% of patients presented the composite endpoint ICU and/or death. Neither ALT elevations, prior liver disease, liver stiffness nor liver steatosis (assessed with CAP) had any effect on outcomes. However, patients with abnormal baseline AST had a higher occurrence of the composite ICU/death (21% versus 9.5%, p = 0.002). Patients ⩾65 years and with an AST level &gt; 50 U/ml at admission had a significantly higher risk of ICU and/or death than those with AST ⩽ 50 U/ml (50% versus 13.3%, p &lt; 0.001). In conclusion, mild liver damage is prevalent in COVID-19 patients, but neither ALT elevation nor liver steatosis influenced hard clinical outcomes. Elevated baseline AST is a strong predictor of hard outcomes, especially in patients ⩾65 years. </jats:p>
  • Access State: Open Access